可乐定对实验性菌血症心血管、肾脏及炎症反应的影响
研究在植入肾与肺动脉血流探针的清醒羊中输注活大肠埃希菌诱导脓毒症,24小时后分别输注高临床剂量可乐定(1.0 μg/kg/h)、低临床剂量可乐定(0.25 μg/kg/h)或溶媒,持续8小时。动物出现高动力、低血压性脓毒症伴急性肾损伤。高剂量可乐定使心率由153±6降至119±7次/分、心输出量由5.6±0.4降至5.0±0.4 L/min,平均动脉压未降低;低剂量可乐定则增加心输出量并引起外周血管扩张。两剂量均引起尿量大幅一过性增加和血浆渗透压升高,高剂量还升高血浆精氨酸加压素;可乐定使IL-10由1.6±0.1升至3.3±0.7 ng/mL而不改变IL-6,并降低直肠温度;脓毒症恢复期高剂量组平均动脉压更快回到基线(P<0.001)。作者认为临床相关剂量可乐定的效应复杂且呈剂量依赖。
要点
- 高临床剂量可乐定1.0 μg/kg/h输注8小时使脓毒症羊心率由153±6降至119±7次/分、心输出量由5.6±0.4降至5.0±0.4 L/min,平均动脉压未降低。
- 低临床剂量可乐定0.25 μg/kg/h增加心输出量并引起外周血管扩张,效应与高剂量相似但较弱。
- 两剂量均引起尿量大幅一过性增加及血浆渗透压升高,高剂量还升高血浆精氨酸加压素。
- 可乐定使IL-10由1.6±0.1升至3.3±0.7 ng/mL而不改变IL-6,并降低直肠温度。
- 脓毒症恢复期高剂量可乐定组平均动脉压更快回到基线(P<0.001)。
适用人群与场景
- 清醒羊,植入肾与肺动脉血流探针,经输注活大肠埃希菌诱导脓毒症,24小时后开始给药。
处置流程与药物剂量
- 脓毒症诱导24小时后输注高临床剂量可乐定1.0 μg/kg/h、低临床剂量可乐定0.25 μg/kg/h或溶媒,持续8小时。
研究设计与关键结果
- 动物模型研究:清醒羊输注活大肠埃希菌诱导高动力、低血压性脓毒症伴急性肾损伤,24小时后输注高临床剂量可乐定1.0 μg/kg/h、低临床剂量可乐定0.25 μg/kg/h或溶媒8小时。
- 高剂量可乐定使心率由153±6降至119±7次/分、心输出量由5.6±0.4降至5.0±0.4 L/min,平均动脉压未降低;低剂量可乐定增加心输出量并引起外周血管扩张。
- 两剂量均引起尿量大幅一过性增加和血浆渗透压升高,高剂量还升高血浆精氨酸加压素。
- 脓毒症使血浆IL-6、IL-10升高,可乐定进一步使IL-10由1.6±0.1升至3.3±0.7 ng/mL,不改变IL-6;可乐定降低直肠温度。
- 脓毒症恢复期高剂量可乐定组平均动脉压更快回到基线(P<0.001)。
证据类型、等级与局限
- 动物实验(清醒羊脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在高动力、低血压性脓毒症中,临床相关剂量可乐定的效应复杂且呈剂量依赖;高临床剂量减弱脓毒症相关的心率和心输出量升高,对动脉压影响小,并引起水利尿、升高精氨酸加压素、降低体温及抗炎作用;低剂量效应相似但较弱,并可致中度血管扩张和心输出量增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Supra-clinical doses of clonidine appear beneficial in experimental sepsis, but there is limited understanding of the effects of clonidine at clinically relevant doses.
METHODS: In conscious sheep, with implanted renal and pulmonary artery flow probes, sepsis was induced by infusion of live Escherichia coli. At 24 h, a high clinical dose of clonidine (HCDC) [1.0 μg/kg/h], a low clinical dose of clonidine (LCDC) [0.25 μg/kg/h] or vehicle, was infused for 8 h.
RESULTS: Animals developed hyperdynamic, hypotensive sepsis with acute kidney injury. The HCDC decreased heart rate (153 ± 6 to 119 ± 7 bpm) and cardiac output (5.6 ± 0.4 to 5.0 ± 0.4 L/min), with no reduction in mean arterial pressure (MAP). In contrast, LCDC increased cardiac output with peripheral vasodilatation. Both doses induced a large transient increase in urine output, an increase in plasma osmolality and, with the high dose, an increase in plasma arginine vasopressin. Sepsis increased plasma interleukin-6 (IL-6) and IL-10 and clonidine further increased IL-10 (1.6 ± 0.1 to 3.3 ± 0.7 ng/mL), but not IL-6. Clonidine reduced rectal temperature. During recovery from sepsis, MAP returned to baseline values more rapidly in the HCDC group (P < 0.001).
CONCLUSIONS: In hyperdynamic, hypotensive sepsis, the effects of clonidine at clinically relevant doses are complex and dose dependent. HCDC attenuated sepsis-related increases in heart rate and cardiac output, with little effect on arterial pressure. It also induced a water diuresis, increased AVP, reduced body temperature, and had an anti-inflammatory action. Low-dose clonidine had similar but less pronounced effects, except that it induced moderate vasodilatation and increased cardiac output.
参考来源
- Calzavacca P, Booth LC, Lankadeva YR, et al. Effects of Clonidine on the Cardiovascular, Renal, and Inflammatory Responses to Experimental Bacteremia. Shock. 2019. PMID: 29489737. doi:10.1097/SHK.0000000000001134
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。